Xilio Therapeutics, Inc.

Perkenalan

Halaman ini memberikan analisis komprehensif tentang riwayat insider trading yang diketahui di Timothy P Clackson. Insider adalah pejabat, direktur, atau investor penting dalam suatu perusahaan. Adalah ilegal bagi insider untuk melakukan perdagangan di perusahaan mereka berdasarkan informasi spesifik dan non-publik. Hal ini tidak berarti bahwa mereka dilarang melakukan perdagangan apa pun di perusahaan mereka sendiri. Namun, mereka harus melaporkan semua perdagangan ke SEC melalui Formulir 4. Meskipun ada pembatasan ini, penelitian akademis menunjukkan bahwa insider – secara umum – cenderung mengungguli pasar di perusahaan mereka sendiri.

Profitabilitas Perdagangan Rata-rata

Profitabilitas perdagangan rata-rata adalah pengembalian rata-rata dari seluruh pembelian pasar terbuka yang dilakukan oleh insider dalam 3 tahun terakhir. Untuk menghitungnya, kami memeriksa setiap pembelian pasar terbuka dan tidak terencana yang dilakukan oleh insider, tidak termasuk semua perdagangan yang ditandai sebagai bagian dari rencana perdagangan 10b5-1. Kami kemudian menghitung kinerja rata-rata perdagangan tersebut selama 3, 6, dan 12 bulan, merata-ratakan setiap durasi tersebut untuk menghasilkan metrik kinerja akhir untuk setiap perdagangan. Terakhir, kami menghitung rata-rata semua metrik kinerja untuk menghitung metrik kinerja bagi insider. Daftar ini hanya mencakup insider yang telah melakukan setidaknya tiga perdagangan dalam 2 tahun terakhir.

Jika profitabilitas perdagangan insider ini adalah "T/A", maka insider tersebut belum melakukan pembelian di pasar terbuka dalam 3 tahun terakhir, atau perdagangan yang mereka lakukan terlalu baru untuk menghitung metrik kinerja yang dapat diandalkan.

Frekuensi Pembaruan: Harian

Lihat daftar insider trader yang paling menguntungkan.

Perusahaan dengan Posisi Insider yang Dilaporkan

Pengajuan SEC menunjukkan Timothy P Clackson telah melaporkan kepemilikan atau perdagangan di perusahaan berikut:

Keamanan Judul Kepemilikan Terbaru yang Dilaporkan
US:ELEV / Elevation Oncology, Inc. Director 0
US: / THESEUS PHARMACEUTICALS INC President and CEO, Director 351.030
US:FMTX / Forma Therapeutics Holdings Inc Director 0
US:XLO / Xilio Therapeutics, Inc. 10% Owner 20.068
US:849CVR014 / CVR F STAR Director 50.486
US:ARIA / ARIAD Pharmaceuticals, Inc. President, R&D, CSO 0
Bagaimana Menafsirkan Grafik

Bagan berikut menunjukkan kinerja saham sekuritas setelah setiap perdagangan pasar terbuka dan tidak terencana yang dilakukan oleh Timothy P Clackson. Perdagangan yang tidak direncanakan adalah perdagangan yang tidak dilakukan sebagai bagian dari rencana perdagangan 10b5-1. Kinerja saham dipetakan sebagai persentase perubahan kumulatif harga saham. Misalnya, jika perdagangan insider dilakukan pada tanggal 1 Januari 2019, grafik akan menunjukkan persentase perubahan harian sekuritas hingga hari ini. Jika harga saham naik dari $10 menjadi $15 selama waktu ini, persentase perubahan harga saham kumulatif akan menjadi 50%. Perubahan harga dari $10 menjadi $20 adalah 100%, dan perubahan harga dari $10 menjadi $5 adalah -50%.

Pada akhirnya, kami mencoba untuk menentukan seberapa dekat korelasi perdagangan insider dengan keuntungan berlebih (positif atau negatif) pada harga saham untuk melihat apakah insider mengatur waktu perdagangannya untuk mendapatkan keuntungan dari informasi insider. Pertimbangkan situasi di mana insider melakukan hal ini. Dalam situasi ini, kita mengharapkan (a) keuntungan positif setelah pembelian, atau (b) keuntungan negatif setelah penjualan. Dalam kasus (a), grafik PEMBELIAN akan menunjukkan serangkaian kurva yang miring ke atas, yang menunjukkan keuntungan positif setelah setiap transaksi pembelian. Dalam kasus (b), grafik PENJUALAN akan menunjukkan serangkaian kurva yang miring ke bawah, yang menunjukkan keuntungan negatif setelah setiap transaksi penjualan.

Namun, hal ini saja tidak cukup untuk menarik kesimpulan. Jika, misalnya, harga saham perusahaan berada dalam kenaikan non-siklus selama bertahun-tahun, maka kita perkirakan semua lahan pasca pembelian akan miring ke atas. Demikian pula, penurunan non-siklus selama bertahun-tahun akan mengakibatkan penurunan pasca-perdagangan. Tak satu pun dari grafik ini menunjukkan aktivitas insider trading.

Indikator terkuat adalah situasi di mana harga saham sangat bersiklus, dan terdapat sinyal positif pada grafik PEMBELIAN dan plot negatif pada grafik PENJUALAN. Situasi ini akan sangat memberi isyarat kepada insider yang mengatur waktu perdagangan demi keuntungan finansial mereka.

Pembelian Insider XLO / Xilio Therapeutics, Inc. - Analisis Keuntungan Jangka Pendek

Di bagian ini, kami menganalisis profitabilitas setiap pembelian insider di pasar terbuka yang tidak direncanakan dan dilakukan pada XLO / Xilio Therapeutics, Inc.. Analisis ini membantu untuk memahami apakah insider secara konsisten menghasilkan keuntungan yang tidak normal, dan layak untuk diikuti. Analisis ini dilakukan selama satu tahun setelah setiap perdagangan dan hasilnya bersifat teoretis .

Tabel berikut ini menunjukkan pembelian pasar terbuka terkini yang bukan merupakan bagian dari rencana perdagangan otomatis.

Tanggal Perdagangan Kode Insider Dilaporkan
Saham
Dilaporkan
Harga
Disesuaikan
Saham
Disesuaikan
Harga
Dasar Biaya Hari ke
Maksimal
Harga di
Maksimal
Maksimal
Keuntungan ($)
Pengembalian Maksimal (%)
Tidak ada perdagangan pasar terbuka yang tidak direncanakan untuk kombinasi insider dan keamanan ini

Harga yang Disesuaikan adalah harga yang disesuaikan secara terpisah. Saham yang Disesuaikan adalah saham yang disesuaikan dengan pembagiannya.

XLO / Xilio Therapeutics, Inc. Insider Trades
Penjualan Insider XLO / Xilio Therapeutics, Inc. - Analisis Kerugian Jangka Pendek

Di bagian ini, kami menganalisis penghindaran kerugian jangka pendek dari setiap penjualan insider di pasar terbuka yang tidak direncanakan dan dilakukan di XLO / Xilio Therapeutics, Inc.. Pola penghindaran kerugian yang konsisten mungkin menunjukkan bahwa transaksi penjualan pada masa depan dapat memprediksi penurunan harga. Analisis ini dilakukan selama satu tahun setelah setiap perdagangan dan hasilnya bersifat teoretis .

Tabel berikut ini menunjukkan penjualan pasar terbuka terkini yang bukan merupakan bagian dari rencana perdagangan otomatis.

Tanggal Perdagangan Kode Insider Dilaporkan
Saham
Dilaporkan
Harga
Disesuaikan
Saham
Disesuaikan
Harga
Dasar Biaya Hari ke
Minimal
Harga di
Minimal
Kerugian Maksimal
Dihindari ($)
Kerugian Maksimal
Dihindari (%)
Tidak ada perdagangan pasar terbuka yang tidak direncanakan untuk kombinasi insider dan keamanan ini

Harga yang Disesuaikan adalah harga yang disesuaikan secara terpisah. Saham yang Disesuaikan adalah saham yang disesuaikan dengan pembagiannya.

XLO / Xilio Therapeutics, Inc. Insider Trades
Riwayat Insider Trading

Tabel ini menunjukkan daftar lengkap perdagangan insider yang dilakukan oleh Timothy P Clackson sebagaimana diungkapkan kepada Securities Exchange Commission (SEC).

Tanggal Berkas Tanggal Trans Formulir Kode Keamanan Kode 10b5-1 Saham Sisa Saham Persen
Mengubah
Saham
Harga
Trans
Nilai
Tersisa
Nilai
2025-07-24 2025-07-23 4 ELEV Elevation Oncology, Inc.
Common Stock
U - Other -47.330 0 -100,00 0,36 -17.039
2023-09-05 2023-09-01 4 ELEV Elevation Oncology, Inc.
Common Stock
G - Gift -15.777 0 -100,00
2022-11-14 2022-11-11 4 THRX Theseus Pharmaceuticals, Inc.
Common Stock
P - Purchase 2.500 351.030 0,72 6,80 16.995 2.386.302
2022-10-14 2022-10-14 4 FMTX Forma Therapeutics Holdings, Inc.
Common Stock
U - Other -7.250 0 -100,00
2022-10-14 2022-10-14 4 FMTX Forma Therapeutics Holdings, Inc.
Common Stock
U - Other -23.590 0 -100,00
2022-06-22 2022-05-31 4 ELEV Elevation Oncology, Inc.
Common Stock
G - Gift -31.553 15.777 -66,67
2022-06-09 2022-06-08 4 FMTX Forma Therapeutics Holdings, Inc.
Common Stock
A - Award 4.500 30.840 17,08
2022-02-23 2022-02-18 4 THRX Theseus Pharmaceuticals, Inc.
Stock Option (right to buy)
A - Award 450.000 450.000
2021-12-22 2021-12-21 4 THRX Theseus Pharmaceuticals, Inc.
Common Stock
P - Purchase 2.600 348.530 0,75 9,76 25.381 3.402.385
2021-10-21 3 XLO Xilio Therapeutics, Inc.
Common Stock
20.068
2021-10-21 3 XLO Xilio Therapeutics, Inc.
Common Stock
70.888
2021-10-06 3 THRX Theseus Pharmaceuticals, Inc.
Common Stock
345.930
2021-06-24 3 ELEV Elevation Oncology, Inc.
Common Stock
47.330
2021-06-21 2021-06-17 4 FMTX Forma Therapeutics Holdings, Inc.
Stock Option (Right to Buy)
A - Award 8.375 8.375
2021-06-21 2021-06-17 4 FMTX Forma Therapeutics Holdings, Inc.
Common Stock
A - Award 2.750 26.340 11,66
2020-10-01 2020-09-30 4 SBPH Spring Bank Pharmaceuticals, Inc.
Common Stock
A - Award 9.422 50.486 22,94
2020-07-01 2020-06-30 4 SBPH Spring Bank Pharmaceuticals, Inc.
Common Stock
A - Award 8.588 41.064 26,44
2020-06-25 2020-06-24 4 SBPH Spring Bank Pharmaceuticals, Inc.
Stock Option (right to buy)
A - Award 7.500 7.500
2020-06-24 2020-06-23 4 FMTX Forma Therapeutics Holdings, Inc.,
Enterprise 5 Junior Stock
S - Sale -35.067 0 -100,00
2020-06-24 2020-06-23 4 FMTX Forma Therapeutics Holdings, Inc.,
Common Stock
P - Purchase 23.590 23.590
2020-06-22 2020-06-18 4 FMTX Forma Therapeutics Holdings, Inc.,
Stock Option (Right to Buy)
A - Award 17.533 0 -100,00
2020-06-18 3 FMTX Forma Therapeutics Holdings, Inc.,
Enterprise 5 Junior Stock
43.144
2020-06-18 3 FMTX Forma Therapeutics Holdings, Inc.,
Enterprise 5 Junior Stock
43.144
2020-06-18 3 FMTX Forma Therapeutics Holdings, Inc.,
Enterprise 5 Junior Stock
43.144
2020-04-01 2020-03-31 4 SBPH Spring Bank Pharmaceuticals, Inc.
Common Stock
A - Award 13.575 32.476 71,82
2020-01-02 2019-12-31 4 SBPH Spring Bank Pharmaceuticals, Inc.
Common Stock
A - Award 7.991 18.901 73,24
2019-10-01 2019-09-30 4 SBPH Spring Bank Pharmaceuticals, Inc.
Common Stock
A - Award 3.670 10.910 50,69
2019-07-11 2019-07-10 4 SBPH Spring Bank Pharmaceuticals, Inc.
Stock Option (right to buy)
A - Award 7.500 7.500
2019-07-01 2019-06-28 4 SBPH Spring Bank Pharmaceuticals, Inc.
Common Stock
A - Award 3.421 7.240 89,58
2019-04-02 2019-03-29 4 SBPH Spring Bank Pharmaceuticals, Inc.
Common Stock
A - Award 1.204 3.819 46,04
2019-01-03 2019-01-02 4 SBPH Spring Bank Pharmaceuticals, Inc.
Common Stock
A - Award 1.083 2.615 70,69
2018-10-02 2018-10-01 4 SBPH Spring Bank Pharmaceuticals, Inc.
Common Stock
A - Award 788 1.532 105,91
2018-07-03 2018-07-02 4 SBPH Spring Bank Pharmaceuticals, Inc.
Common Stock
A - Award 744 744
2018-03-05 2018-03-01 4 SBPH Spring Bank Pharmaceuticals, Inc.
Stock Option (right to buy)
A - Award 11.000 11.000
2018-03-05 3 SBPH Spring Bank Pharmaceuticals, Inc.
No securities are beneficially owned
0
2017-02-16 2017-02-16 4 ARIA ARIAD PHARMACEUTICALS INC
Restricted Stock Units
D - Sale to Issuer -14.550 0 -100,00
2017-02-16 2017-02-16 4 ARIA ARIAD PHARMACEUTICALS INC
Restricted Stock Units
D - Sale to Issuer -72.980 0 -100,00
2017-02-16 2017-02-16 4 ARIA ARIAD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy)
D - Sale to Issuer -87.125 0 -100,00
2017-02-16 2017-02-16 4 ARIA ARIAD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy)
D - Sale to Issuer -65.000 0 -100,00
2017-02-16 2017-02-16 4 ARIA ARIAD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy)
D - Sale to Issuer -82.000 0 -100,00
2017-02-16 2017-02-16 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
D - Sale to Issuer -577 0 -100,00
2017-02-16 2017-02-16 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
D - Sale to Issuer -219.867 0 -100,00
2017-02-07 2017-02-06 4 ARIA ARIAD PHARMACEUTICALS INC
Restricted Stock Units
A - Award 14.550 14.550
2017-02-02 2017-01-31 4 ARIA ARIAD PHARMACEUTICALS INC
Restricted Stock Units
M - Exercise -29.333 0 -100,00
2017-02-02 2017-01-31 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
F - Taxes -9.610 219.867 -4,19 23,82 -228.886 5.236.682
2017-02-02 2017-01-31 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
M - Exercise 29.333 229.477 14,66
2016-10-25 2016-10-24 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
S - Sale X -19.638 197.884 -9,03 9,56 -187.739 1.891.771
2016-09-28 2016-09-28 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
S - Sale X -8.750 217.522 -3,87 13,98 -122.311 3.040.610
2016-09-28 2016-09-26 4 ARIA ARIAD PHARMACEUTICALS INC
Performance stock unit
M - Exercise -17.500 0 -100,00
2016-09-28 2016-09-26 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
M - Exercise 17.500 226.272 8,38
2016-09-23 2016-09-22 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
S - Sale X -20.000 208.772 -8,74 13,43 -268.536 2.803.140
2016-09-16 2016-09-15 4 ARIA ARIAD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy)
M - Exercise -59.369 0 -100,00
2016-09-16 2016-09-15 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
S - Sale X -59.369 228.772 -20,60 11,73 -696.398 2.683.496
2016-09-16 2016-09-15 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
M - Exercise X 59.369 288.141 25,95 7,82 464.266 2.253.263
2016-08-23 2016-08-22 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
S - Sale X -19.436 228.772 -7,83 10,47 -203.538 2.395.746
2016-08-15 2016-08-12 4 ARIA ARIAD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy)
M - Exercise -25.000 0 -100,00
2016-08-15 2016-08-12 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
S - Sale X -25.000 248.208 -9,15 10,50 -262.500 2.606.184
2016-08-15 2016-08-12 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
M - Exercise X 25.000 273.208 10,07 7,69 192.250 2.100.970
2016-07-25 2016-07-22 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
S - Sale X -18.286 248.208 -6,86 8,11 -148.230 2.012.024
2016-07-05 2016-07-01 4 ARIA ARIAD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy)
M - Exercise -30.000 0 -100,00 3,25 -97.500
2016-07-05 2016-07-01 4 ARIA ARIAD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy)
M - Exercise -31.422 0 -100,00 4,49 -141.085
2016-07-05 2016-07-01 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
S - Sale X -30.000 266.494 -10,12 7,48 -224.481 1.994.095
2016-07-05 2016-07-01 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
M - Exercise X 30.000 296.494 11,26 3,25 97.500 963.606
2016-07-05 2016-07-01 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
S - Sale X -31.422 266.494 -10,55 7,48 -235.153 1.994.361
2016-07-05 2016-07-01 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
M - Exercise X 31.422 297.916 11,79 4,49 141.085 1.337.643
2016-06-23 2016-06-22 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
S - Sale X -23.999 264.742 -8,31 7,28 -174.638 1.926.501
2016-05-25 2016-05-23 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
S - Sale X -17.762 288.741 -5,80 8,08 -143.430 2.331.612
2016-05-02 2016-05-02 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
S - Sale X -11.700 306.503 -3,68 7,13 -83.478 2.186.868
2016-05-02 2016-04-29 4 ARIA ARIAD PHARMACEUTICALS INC
Restricted Stock Units
M - Exercise -23.400 0 -100,00
2016-05-02 2016-04-29 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
M - Exercise 23.400 318.203 7,94
2016-04-25 2016-04-22 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
S - Sale X -21.409 294.803 -6,77 7,37 -157.864 2.173.789
2016-03-23 2016-03-22 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
S - Sale X -23.834 316.212 -7,01 6,58 -156.871 2.081.244
2016-03-22 2016-03-19 4 ARIA ARIAD PHARMACEUTICALS INC
Restricted Stock Units
M - Exercise -10.833 0 -100,00
2016-03-22 2016-03-19 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
S - Sale X -5.417 340.046 -1,57 6,47 -35.039 2.199.520
2016-03-22 2016-03-19 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
M - Exercise 10.833 345.463 3,24
2016-03-09 2016-03-07 4 ARIA ARIAD PHARMACEUTICALS INC
Restricted Stock Units
A - Award 26.180 26.180
2016-03-09 2016-03-07 4 ARIA ARIAD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy)
A - Award 87.125 87.125
2016-03-03 2016-03-03 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
S - Sale X -9.625 334.630 -2,80 6,12 -58.867 2.046.631
2016-03-03 2016-03-02 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
S - Sale -25.047 344.255 -6,78 6,00 -150.282 2.065.530
2016-03-03 2016-03-01 4 ARIA ARIAD PHARMACEUTICALS INC
Performance stock unit
A - Award 38.500 38.500
2016-03-03 2016-03-01 4 ARIA ARIAD PHARMACEUTICALS INC
Performance stock unit
M - Exercise -19.250 19.250 -50,00
2016-03-03 2016-03-01 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
M - Exercise 19.250 369.302 5,50
2016-02-03 2016-02-01 4 ARIA ARIAD PHARMACEUTICALS INC
Restricted Stock Units
M - Exercise -29.333 29.333 -50,00
2016-02-03 2016-02-01 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
S - Sale X -14.667 350.052 -4,02 4,81 -70.517 1.683.015
2016-02-03 2016-02-01 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
M - Exercise 29.333 364.719 8,75
2015-09-28 2015-09-28 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
S - Sale X -8.750 334.086 -2,55 6,46 -56.560 2.159.532
2015-09-28 2015-09-24 4 ARIA ARIAD PHARMACEUTICALS INC
Performance stock unit
A - Award 35.000 35.000
2015-09-28 2015-09-24 4 ARIA ARIAD PHARMACEUTICALS INC
Performance stock unit
M - Exercise -17.500 17.500 -50,00
2015-09-28 2015-09-24 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
M - Exercise 17.500 342.836 5,38
2015-07-16 2015-07-16 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
S - Sale X -7.000 325.336 -2,11 8,54 -59.797 2.779.150
2015-07-16 2015-07-15 4 ARIA ARIAD PHARMACEUTICALS INC
Performance stock unit
M - Exercise -14.000 0 -100,00
2015-07-16 2015-07-15 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
M - Exercise 14.000 332.336 4,40
2015-04-30 2015-04-29 4 ARIA ARIAD PHARMACEUTICALS INC
Restricted Stock Units
A - Award 70.200 70.200
2015-04-27 2015-04-23 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
S - Sale X -123.766 316.548 -28,11 9,50 -1.175.777 3.007.206
2015-03-23 2015-03-23 4 ARIA ARIAD PHARMACEUTICALS INC
Restricted Stock Units
M - Exercise -13.333 0 -100,00
2015-03-23 2015-03-23 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
S - Sale X -6.667 440.314 -1,49 8,55 -57.016 3.765.565
2015-03-23 2015-03-23 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
M - Exercise 13.333 446.981 3,07
2015-03-23 2015-03-20 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
S - Sale X -5.417 433.648 -1,23 8,84 -47.910 3.835.313
2015-03-23 2015-03-19 4 ARIA ARIAD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy)
M - Exercise -20.657 0 -100,00
2015-03-23 2015-03-19 4 ARIA ARIAD PHARMACEUTICALS INC
Restricted Stock Units
M - Exercise -10.833 10.833 -50,00
2015-03-23 2015-03-19 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
S - Sale -20.657 440.314 -4,48 9,00 -185.913 3.962.826
2015-03-23 2015-03-19 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
M - Exercise 20.657 460.971 4,69 7,56 156.167 3.484.941
2015-03-23 2015-03-19 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
M - Exercise 10.833 439.065 2,53
2015-02-24 2015-02-20 4 ARIA ARIAD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy)
M - Exercise -24.036 31.422 -43,34
2015-02-24 2015-02-20 4 ARIA ARIAD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy)
M - Exercise -24.999 0 -100,00
2015-02-24 2015-02-20 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
S - Sale X -24.036 428.232 -5,31 8,00 -192.288 3.425.856
2015-02-24 2015-02-20 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
M - Exercise 24.036 452.268 5,61 4,49 107.922 2.030.683
2015-02-24 2015-02-20 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
S - Sale X -24.999 428.232 -5,52 8,00 -199.992 3.425.856
2015-02-24 2015-02-20 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
M - Exercise 24.999 453.231 5,84 2,62 65.497 1.187.465
2015-02-04 2015-02-02 4 ARIA ARIAD PHARMACEUTICALS INC
Restricted Stock Units
M - Exercise -29.334 58.666 -33,33
2015-02-04 2015-02-02 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
S - Sale X -14.667 428.232 -3,31 6,33 -92.820 2.710.066
2015-02-04 2015-02-02 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
M - Exercise 29.334 442.899 7,09
2014-07-17 2014-07-15 4 ARIA ARIAD PHARMACEUTICALS INC
Performance stock unit
M - Exercise -14.000 14.000 -50,00
2014-07-17 2014-07-15 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
F - Taxes -4.564 413.565 -1,09 5,57 -25.421 2.303.557
2014-07-17 2014-07-15 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
M - Exercise 14.000 418.129 3,46
2014-04-03 2014-04-02 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
S - Sale X -6.500 403.028 -1,59 8,21 -53.337 3.307.127
2014-04-03 2014-04-01 4 ARIA ARIAD PHARMACEUTICALS INC
Restricted Stock Units
M - Exercise -13.000 0 -100,00
2014-04-03 2014-04-01 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
M - Exercise 13.000 409.528 3,28
2014-03-21 2014-03-21 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
S - Sale X -6.667 394.377 -1,66 7,89 -52.583 3.110.451
2014-03-21 2014-03-20 4 ARIA ARIAD PHARMACEUTICALS INC
Restricted Stock Units
M - Exercise -13.333 13.333 -50,00
2014-03-21 2014-03-20 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
M - Exercise 13.333 401.044 3,44
2014-03-21 2014-03-19 4 ARIA ARIAD PHARMACEUTICALS INC
Restricted Stock Units
M - Exercise -10.834 21.666 -33,34
2014-03-21 2014-03-19 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
F - Taxes -3.442 387.711 -0,88 8,19 -28.190 3.175.353
2014-03-21 2014-03-19 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
M - Exercise 10.834 391.153 2,85
2014-02-04 2014-01-31 4 ARIA ARIAD PHARMACEUTICALS INC
Restricted Stock Units
A - Award 88.000 88.000
2013-12-20 2013-12-19 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
S - Sale X -9.750 380.319 -2,50 5,14 -50.115 1.954.840
2013-12-20 2013-12-18 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
M - Exercise 19.500 390.069 5,26
2013-09-10 2013-09-06 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
S - Sale X -8.449 370.451 -2,23 22,00 -185.878 8.149.922
2013-07-18 2013-07-18 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
S - Sale X -14.000 378.900 -3,56 19,79 -277.045 7.498.014
2013-07-17 2013-07-15 4 ARIA ARIAD PHARMACEUTICALS INC
Performance stock unit
M - Exercise -28.000 28.000 -50,00
2013-07-17 2013-07-15 4 ARIA ARIAD PHARMACEUTICALS INC
Performance stock unit
A - Award 56.000 56.000
2013-07-17 2013-07-15 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
M - Exercise 28.000 392.900 7,67
2013-04-03 2013-04-02 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
S - Sale -6.500 363.705 -1,76 18,04 -117.245 6.560.402
2013-04-03 2013-04-01 4 ARIA ARIAD PHARMACEUTICALS INC
Restricted Stock Units
M - Exercise -13.000 0 -100,00
2013-04-03 2013-04-01 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
M - Exercise 13.000 370.205 3,64
2013-03-26 2013-03-25 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
S - Sale -19.167 357.205 -5,09 18,87 -361.766 6.742.030
2013-03-26 2013-03-22 4 ARIA ARIAD PHARMACEUTICALS INC
Restricted Stock Units
M - Exercise -38.333 0 -100,00
2013-03-26 2013-03-22 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
M - Exercise 38.333 376.372 11,34
2013-03-22 2013-03-22 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
S - Sale -6.667 338.039 -1,93 19,46 -129.718 6.577.123
2013-03-22 2013-03-20 4 ARIA ARIAD PHARMACEUTICALS INC
Restricted Stock Units
M - Exercise -13.334 0 -100,00
2013-03-22 2013-03-20 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
M - Exercise 13.334 344.706 4,02
2013-03-20 2013-03-19 4 ARIA ARIAD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy)
A - Award 65.000 65.000
2013-03-20 2013-03-19 4 ARIA ARIAD PHARMACEUTICALS INC
Restricted Stock Units
A - Award 32.500 32.500
2013-03-05 2013-03-04 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
S - Sale X -9.838 331.372 -2,88 21,00 -206.598 6.958.812
2013-01-17 2013-01-15 4 ARIA ARIAD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy)
M - Exercise -8.631 17.262 -33,33
2013-01-17 2013-01-15 4 ARIA ARIAD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy)
M - Exercise -44.542 0 -100,00
2013-01-17 2013-01-15 4 ARIA ARIAD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy)
M - Exercise -4.766 0 -100,00
2013-01-17 2013-01-15 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
M - Exercise 8.631 341.210 2,60 7,82 67.494 2.668.262
2013-01-17 2013-01-15 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
M - Exercise 44.542 332.579 15,46 4,49 199.994 1.493.280
2013-01-17 2013-01-15 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
M - Exercise 4.766 288.037 1,68 5,23 24.926 1.506.434
2012-12-21 2012-12-20 4 ARIA ARIAD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy)
M - Exercise -27.000 4.766 -85,00
2012-12-21 2012-12-20 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
M - Exercise 27.000 282.940 10,55 5,23 141.210 1.479.776
2012-12-20 2012-12-18 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
F - Taxes -8.142 255.940 -3,08 20,18 -164.306 5.164.869
2012-12-20 2012-12-18 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
M - Exercise 19.500 264.082 7,97
2012-09-04 2012-08-30 4 ARIA ARIAD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy)
M - Exercise -1 24.999 0,00
2012-09-04 2012-08-30 4 ARIA ARIAD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy)
M - Exercise -10.000 30.000 -25,00
2012-09-04 2012-08-30 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
M - Exercise 1 244.170 0,00 2,62 3 639.725
2012-09-04 2012-08-30 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
M - Exercise 10.000 244.169 4,27 3,25 32.500 793.549
2012-08-16 2012-08-15 4 ARIA ARIAD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy)
M - Exercise -36.843 0 -100,00
2012-08-16 2012-08-15 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
S - Sale X -36.843 234.169 -13,59 20,00 -736.860 4.683.380
2012-08-16 2012-08-15 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
M - Exercise 36.843 271.012 15,73 7,56 278.533 2.048.851
2012-08-01 2012-07-30 4 ARIA ARIAD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy)
M - Exercise -23.234 31.766 -42,24
2012-08-01 2012-07-30 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
S - Sale X -23.234 234.169 -9,03 19,00 -441.446 4.449.211
2012-08-01 2012-07-30 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
M - Exercise 23.234 257.403 9,92 5,23 121.514 1.346.218
2012-05-04 2012-05-02 4 ARIA ARIAD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy)
M - Exercise -20.000 0 -100,00
2012-05-04 2012-05-02 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
S - Sale X -20.000 233.778 -7,88 17,00 -340.000 3.974.226
2012-05-04 2012-05-02 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
M - Exercise 20.000 253.778 8,56 7,44 148.800 1.888.108
2012-04-17 2012-04-17 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
S - Sale X -7.111 233.778 -2,95 15,00 -106.665 3.506.670
2012-04-17 2012-04-13 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
S - Sale X -31.600 240.889 -11,60 14,83 -468.628 3.572.384
2012-04-03 2012-04-03 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
S - Sale X -5.200 272.489 -1,87 16,18 -84.134 4.408.763
2012-04-03 2012-04-01 4 ARIA ARIAD PHARMACEUTICALS INC
Restricted Stock Units
M - Exercise -13.000 26.000 -33,33
2012-04-03 2012-04-01 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
M - Exercise 13.000 277.689 4,91
2012-04-03 2012-03-26 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
S - Sale X -26.061 264.689 -8,96 16,34 -425.876 4.325.415
2012-03-28 2012-03-26 4 ARIA ARIAD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy)
M - Exercise -7.500 0 -100,00
2012-03-28 2012-03-26 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
S - Sale X -7.500 290.750 -2,51 16,00 -120.000 4.652.000
2012-03-28 2012-03-26 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
M - Exercise 7.500 298.250 2,58 6,39 47.925 1.905.818
2012-03-26 2012-03-23 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
S - Sale X -15.333 290.750 -5,01 15,41 -236.211 4.479.120
2012-03-26 2012-03-22 4 ARIA ARIAD PHARMACEUTICALS INC
Restricted Stock Units
M - Exercise -38.333 38.333 -50,00
2012-03-26 2012-03-22 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
M - Exercise 38.333 306.083 14,32
2012-03-21 2012-03-20 4 ARIA ARIAD PHARMACEUTICALS INC
Restricted Stock Units
A - Award 40.000 40.000
2012-03-21 2012-03-20 4 ARIA ARIAD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy)
A - Award 82.000 82.000
2012-03-21 2012-03-20 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
S - Sale -36.400 267.750 -11,97 15,02 -546.622 4.020.829
2012-03-21 2012-03-19 4 ARIA ARIAD PHARMACEUTICALS INC
Restricted Stock Units
M - Exercise 91.000 0 -100,00
2012-03-21 2012-03-19 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
M - Exercise -91.000 304.150 -23,03
2012-03-19 2012-03-16 4 ARIA ARIAD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy)
M - Exercise -8.449 0 -100,00
2012-03-19 2012-03-16 4 ARIA ARIAD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy)
M - Exercise -6.615 0 -100,00
2012-03-19 2012-03-16 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
M - Exercise 8.449 213.150 4,13 4,19 35.401 893.098
2012-03-19 2012-03-16 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
M - Exercise 6.615 204.701 3,34 4,05 26.791 829.039
2012-02-16 2012-02-14 4 ARIA ARIAD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy)
M - Exercise -16.500 16.500 -50,00
2012-02-16 2012-02-14 4 ARIA ARIAD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy)
M - Exercise -41.551 8.449 -83,10
2012-02-16 2012-02-14 4 ARIA ARIAD PHARMACEUTICALS INC
Employee Stock Option (Right to Buy)
M - Exercise -18.385 6.615 -73,54
2012-02-16 2012-02-14 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
S - Sale X -76.436 119.882 -38,93 15,12 -1.155.781 1.812.724
2012-02-16 2012-02-14 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
M - Exercise 16.500 196.318 9,18 3,90 64.350 765.640
2012-02-16 2012-02-14 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
M - Exercise 41.551 179.818 30,05 4,19 174.099 753.437
2012-02-16 2012-02-14 4 ARIA ARIAD PHARMACEUTICALS INC
Common Stock
M - Exercise 18.385 138.267 15,34 4,05 74.459 559.981
P
Pasar terbuka atau pembelian swasta atas sekuritas non-derivatif atau derivatif
S
Pasar terbuka atau penjualan pribadi atas sekuritas non-derivatif atau derivatif
A
Hibah, penghargaan, atau perolehan sekuritas lainnya dari perusahaan (seperti opsi)
C
Konversi derivatif
D
Penjualan atau pengalihan surat berharga kembali kepada perusahaan
F
Pembayaran harga pelaksanaan atau kewajiban perpajakan dengan menggunakan sebagian surat berharga yang diterima dari perusahaan
G
Pemberian surat berharga oleh atau kepada insider
K
Swap ekuitas dan transaksi lindung nilai serupa
M
Penggunaan atau konversi sekuritas derivatif yang diterima dari perusahaan (seperti opsi)
V
Suatu transaksi dilaporkan secara sukarela pada Formulir 4
J
Lainnya (disertai catatan kaki yang menjelaskan transaksi)